ArticleCase reports in cardiology2026
Recurrent Ventricular Fibrillation Associated With Graves' Disease: A Case Report.
Article in Case reports in cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recurrent Ventricular Fibrillation Associated With Graves' Disease: A Case Report.Case reports in cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although tachyarrhythmias are associated with thyrotoxicosis, the association with ventricular fibrillation is unknown. This case reports a recurrent ventricular fibrillation with Graves' disease that was successfully treated with an implantable cardioverter defibrillator. A 33-year-old woman presented with ventricular fibrillation cardiac arrest. She was diagnosed with Graves' disease and was taking antithyroid drugs, but her hyperthyroidism was poorly controlled. The patient received intensive care unit care, including extracorporeal membrane oxygenator, ventilator, and renal replacement therapy. Implantable cardioverter defibrillator was implanted for the secondary prevention of ventricular fibrillation. Two months after the procedure, ventricular fibrillation recurred, and an implantable cardioverter defibrillator successfully prevented sudden cardiac death. She maintained a normal sinus rhythm and normal thyroid function after receiving radioactive iodine-131 therapy. Ventricular fibrillation is a rare but fatal manifestation in patients with hyperthyroidism. Implantable cardioverter defibrillator should be considered, especially in patients with poorly controlled hyperthyroidism, for the prevention of sudden cardiac death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.